StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Nirav Chheda, Nirmal Bang Securities

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byNirav Chheda, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via CNBC Awaaz.

Entry₹1,240.4Inferred
Target₹1,320
Total upside +6.42%
Stop loss₹1,215-2.05% risk
CMP₹1,251.9Just now
Active+0.93%+5.44%upside left 13d left
Follow Nirav Chheda for new calls(19% target hit, 78 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 3 other Swing calls on DRREDDYSee 151 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Sept, 9:14 am IST
8 supporting3 opposing
Supports the BUY call (8)

MACD above its signal line — bullish momentum

Technicals · macd·30 Sept · today

Past week's volume 1.6× the 30-day average

Technicals · volume·29 Sept · yesterday

Hikma signs exclusive licensing and distribution agreement with Dr. Reddy’s Laboratories for Nicotinell across MENA

NewsGoogle News·28 Sept · yesterday

(opens in new tab)

5 advisors have active short-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·28 Sept · yesterday

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·28 Sept · yesterday

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

RSI at 77 — overbought territory

Technicals · rsi·30 Sept · today

Dr. Reddy's faces securities fraud probe after Q1 earnings hit by semaglutide batch issues.

NewsGoogle News·25 Sept · 5d ago

(opens in new tab)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·25 Sept · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.